Nu-Med Plus (NUMD) Other financing activities (2018 - 2021)

Nu-Med Plus has disclosed Other financing activities across 4 years of filings, most recently posting $30000.0 for Q1 2021.

• In Q1 2021, Other financing activities changed N/A year-over-year to $30000.0; the TTM figure through Mar 2021 stood at $416842.0 (up 857.89% YoY), while the FY2020 annual figure was $386842.0, up 673.68% from the prior year.
• Other financing activities came in at $30000.0 for Q1 2021 at Nu-Med Plus, up from $28260.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $232170.0 in Q2 2020 to a low of -$225016.0 in Q4 2019.
• Average Other financing activities over 4 years is $55153.5, with a median of $85008.0 recorded in 2019.
• The largest YoY upside for Other financing activities was 1177.37% in 2019 against a maximum downside of 248.11% in 2019.
• Over 4 years, Other financing activities stood at $151930.0 in 2018, then slumped by 248.11% to -$225016.0 in 2019, then soared by 112.56% to $28260.0 in 2020, then gained by 6.16% to $30000.0 in 2021.
• Per Business Quant data, the three most recent Other financing activities figures were $30000.0 in Q1 2021, $28260.0 in Q4 2020, and $126412.0 in Q3 2020.